With the extension of life span over the past several decades, the age-related loss of muscle
mass and strength that characterizes sarcopenia is becoming more evident and thus, has a …

The world is facing the new challenges of an aging population, and understanding the
process of aging has therefore become one of the most important global concerns …

Sarcopenia, the age-related loss of skeletal muscle mass, is a significant public health
concern that continues to grow in relevance as the population ages. Certain conditions have …

Sarcopenia has been defined as a progressive decline of skeletal muscle mass, strength,
and functions in elderly people. It is accompanied by physical frailty, functional disability …

Sarcopenia is a debilitating skeletal muscle disease that accelerates in the last decades of
life and is characterized by marked deficits in muscle strength, mass, quality, and metabolic …

Sarcopenia, the age-related loss of skeletal muscle mass and function, affects 5–13% of
individuals aged over 60 years. While rodents are widely-used model organisms, which …

Sarcopenia is the age‐related decline in muscle mass and function without any underlying
disease. The exact molecular mechanisms responsible for this pathology remain unknown …

Sarcopenia is the degenerative loss of muscle mass and function with aging. Recently
sarcopenia was recognized as a clinical disease by the International Classification of …

Sarcopenia is a progressive and widespread skeletal muscle disease that is related to an
increased possibility of adverse consequences such as falls, fractures, physical disabilities …

There is pressing need to understand the aging process to better cope with its associated
physical and societal costs. The age-related muscle wasting known as sarcopenia is a major …